Viracta Therapeutics Inc (NASDAQ:VIRX)

1.58
Delayed Data
As of 3:59pm ET
 0.00 / 0.00%
Today’s Change
1.21
Today|||52-Week Range
5.75
+8.22%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Viracta Therapeutics Inc have a median target of 11.00, with a high estimate of 35.00 and a low estimate of 7.00. The median estimate represents a +596.20% increase from the last price of 1.58.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Viracta Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.31
Sales
$0.00
Reporting Date
May 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -15.74%
 
 
 
 
 
 
Growthannually 9.85%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.